Dr. Muhammad M. Shamim
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
700 University Blvd
Galveston, TX 77550
Who else practices at this address →
Galveston County includes primary care (1% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- Baylor College of Medicine (2019)
- Years since graduation
- 7
- In the NPI registry since
- 2019
Licensed in Texas since 2025, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Medical school: Baylor College of Medicine
- 2019Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
TX license V9131 (first issued 2025; active) -
Ophthalmology Physician
TX license V9131 (first issued 2025; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Texas Medical Branch Galveston Galveston, TX
Medical groups
- Utmb Faculty Group Practice (1,101 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Galveston, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $72.25 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $72.25 |
|---|
| Food and Beverage | $72.25 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.